You are here
News & Events
Vertex Appoints Ken Horton as Executive Vice President and Chief Legal Officer and Announces Retirement of Nancy Wysenski as Chief Commercial Officer
"Ken brings to Vertex more than 20 years of broad experience, with a focus on managing legal and compliance functions for large global health care companies, most recently as
"Nancy was critical in establishing a talented commercial team that led the successful launch of Vertex's first two medicines and in preparing the company for continued growth in the coming years. After more than 30 years in health care, she has chosen to move on to the next chapter of her life, and we wish her all the best in retirement.
"I also thank Ty for his work to advance the capabilities of our Legal and Compliance teams as we prepared to become a commercial company for the first time in our history. His leadership was instrumental during a time of rapid growth for our company, and I look forward to his close collaboration with Ken in the coming months."
Vertex creates new possibilities in medicine. Our team discovers, develops and commercializes innovative therapies so people with serious diseases can lead better lives.
Vertex scientists and our collaborators are working on new medicines to cure or significantly advance the treatment of hepatitis C, cystic fibrosis, rheumatoid arthritis, epilepsy and other life-threatening diseases.
Founded more than 20 years ago in
Vertex's press releases are available at www.vrtx.com.
(VRTX - GEN)
News Provided by Acquire Media